Real-World Immune-Related Adverse Events in Patients With Early Triple-Negative Breast Cancer Who Received Pembrolizumab

Athira Jayan, Jasmine S. Sukumar, Benjamin Fangman, Tejal Patel, Akshara Singareeka Raghavendra, Diane Liu, Sarah Pasyar, Ronald Rauch, Karen Basen-Engquist, Debasish Tripathy, Yinghong Wang, Sonya S. Khan, Carlos H. Barcenas

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The real-world breakdown of immune adverse events was different without the identification of associated factors.

Original languageEnglish (US)
JournalJCO Oncology Practice
DOIs
StateAccepted/In press - 2024

ASJC Scopus subject areas

  • Oncology
  • Health Policy
  • Oncology(nursing)

Fingerprint

Dive into the research topics of 'Real-World Immune-Related Adverse Events in Patients With Early Triple-Negative Breast Cancer Who Received Pembrolizumab'. Together they form a unique fingerprint.

Cite this